Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population

doi:10.3748/wjg.v20.i38.14010

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 38

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6706)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

357

WORD

203

HTML

3526

Figures (1-2)

144

Tables (1-5)

144

Sum=4374

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1233

Download

1099

Sum=2332

Oct 14, 2014 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Oct 14, 2014; 20(38): 14010-14017
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.14010

Table 1 Clinical characteristics between the control group and the nonalcoholic fatty liver disease group n (%)

Item	Control	NAFLD	P value	Frequency of disorders in NAFLD group
Gender (n)				--
Male	200	200	1.0	--
Female	100	100	1.0	--
Age (yr)	39.5 ± 9.1	40.7 ± 9.7	0.11	--
BMI (kg/m²)	22.1 ± 2.8	26.3 ± 4.2	< 0.001	186 (62.0)
Blood pressure (mmHg)	--	--	--	64 (21.3)
Systolic pressure	119 ± 13	127 ± 13	< 0.001	--
Diastolic pressure	75 ± 10	82 ± 9	< 0.001	--
HDL (mmol/L)	--	--	--	128 (42.7)
Male	1.4 ± 0.2	1.1 ± 0.2	< 0.001	107 (53.5)
Female	1.4 ± 0.2	1.3 ± 0.3	< 0.001	21 (21.0)
Total cholesterol (mmol/L)	4.7 ± 0.5	5.4 ± 1.0	< 0.001	122 (40.7)
TG (mmol/L)	1.0 ± 0.5	2.5 ± 2.5	< 0.001	119 (39.7)
UA (μmol/L)	--	--	--	104 (34.7)
Male	335.3 ± 51.2	415.5 ± 97.2	< 0.001	89 (44.5)
Female	241.3 ± 39.5	324.0 ± 83.6	< 0.001	15 (15.0)
LDL (mmol/L)	2.7 ± 0.5	3.3 ± 0.9	< 0.001	90 (30.0)
FPI (μU/mL)	6.0 ± 3.1	10.62 ± 4.5	< 0.001	--
HOMA-IR	1.2 ± 0.7	2.4 ± 1.2	< 0.001	74 (24.7)
FPG (mmol/L)	4.8 ± 0.5	5.3 ± 1.1	< 0.001	67 (22.3)
ALT (U/L)	19.0 ± 8.7	42.1 ± 32.6	< 0.001	114 (38.0)
AST (U/L)	24.1 ± 4.9	33.1 ± 14.8	< 0.001	148 (49.3)

NAFLD: Nonalcoholic fatty liver disease; BMI: Body mass index; HDL: High-density lipoprotein cholesterol; TG: Triglyceride; UA: Uric acid; LDL: Low-density lipoprotein cholesterol; FPI: Fasting plasma insulin; HOMA-IR: Homeostasis model of assessment for insulin resistance index; FPG: Fasting plasma glucose; ALT: Alanine aminotranferase; AST: Aspartate aminotransferase.

Table 2 Association between Apolipoprotein C3 (-455T>C) polymorphism and nonalcoholic fatty liver disease susceptibility n (%)

Genotype	Group		P value	Adjusted OR (95%CI)
	Control group	NAFLD group
TT	134 (44.7)	94 (31.3)	-	1
TC	123 (41.0)	131 (43.7)	0.009¹	1.77 (1.16-2.72)¹
CC	43 (14.3)	75 (25.0)	< 0.001²	2.80 (1.64-4.79)²

¹TC vs TT;

²CC vs TT. NAFLD: Nonalcoholic fatty liver disease.

Table 3 Correlation between Apolipoprotein C3 (-455T>C) polymorphism and insulin resistance, impaired glucose tolerance in the nonalcoholic fatty liver disease group n (%)

Genotype	Metabolic component		P value	Adjusted OR (95%CI)
	Non-IR	IR
TT	78 (34.5)	16 (21.7)	-	1
TC	99 (43.8)	32 (43.2)	0.06¹	1.96 (0.97-3.96)¹
CC	49 (21.7)	26 (35.1)	0.00²	3.24 (1.52-6.92)²
	Non-IGT	IGT
TT	77 (33.0)	17 (25.4)	-	1
TC	98 (42.1)	33 (49.2)	0.23¹	-
CC	58 (24.9)	17 (25.4)	0.89²	-

¹TC vs TT;

²CC vs TT. IR: Insulin resistance; IGT: Impaired glucose tolerance.

Table 4 Correlation between Apolipoprotein C3 (-455T>C) polymorphism and hypertension, dyslipidemia in the nonalcoholic fatty liver disease group n (%)

Genotype	Metabolic component		P value	Adjusted OR (95%CI)
	Non-hypertension	Hypertension
TT	82 (34.7)	12 (18.8)	-	1
TC	102 (43.2)	29 (45.3)	0.04¹	2.16 (1.02-4.57)¹
CC	52 (22.1)	23 (35.9)	0.003²	3.42 (1.53-7.60)²
	Non-hypertriglyceridemia	Hypertriglyceridemia
TT	71 (39.3)	23 (19.3)	-	1
TC	77 (42.5)	54 (45.4)	0.02¹	2.03 (1.12-3.68)¹
CC	33 (18.2)	42 (35.3)	< 0.001²	3.80 (1.95-7.41)²
	Normal HDL	Low HDL
TT	63 (36.6)	31 (24.2)	-	1
TC	75 (43.6)	56 (43.8)	0.30¹	1.36 (0.76 -2.42)¹
CC	34 (19.8)	41 (32.0)	0.01²	2.34 (1.21 -4.52)²
	Non-hypercholesterolemia	Hypercholesterolemia
TT	57 (32.0)	37 (30.3)	-	1
TC	81 (45.5)	50 (41.0)	0.52¹	-
CC	40 (22.5)	35 (28.7)	0.20²	-
	Normal LDL	Increased LDL
TT	65 (31.0)	29 (32.2)	-	1
TC	89 (42.3)	42 (46.7)	0.41¹	-
CC	56 (26.7)	19 (21.1)	0.33²	-

¹TC vs TT;

²CC vs TT. HDL: High-density lipoprotein cholesterol; LDL: Low-density lipoprotein cholesterol.

Table 5 Apolipoprotein C3 (-455T>C) polymorphism among different ethnicities: data from the literature n (%)

Ref.	Ethnicity	*Genotype of APOC3* (-455T>C)**
Ref.	Ethnicity	TT	TC	CC
Kozlitina et al[10]	African Americans	106 (8.7)	484 (39.9)	623 (51.4)
Kozlitina et al[10]	Europeans	316 (38.4)	390 (47.4)	117 (14.2)
Kozlitina et al[10]	Hipanics	163 (37.7)	209 (48.4)	60 (13.9)
Hyysalo et al[12]	Finns	145 (33.7)	190 (44.2)	95 (22.1)
Niu et al[20]	Northern Chinese	206 (25.8)	375 (46.9)	218 (27.3)

Citation: Li MR, Zhang SH, Chao K, Liao XH, Yao JY, Chen MH, Zhong BH. Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population. World J Gastroenterol 2014; 20(38): 14010-14017
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/14010.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i38.14010